EurekaMag.com logo
+ Site Statistics
References:
53,623,987
Abstracts:
29,492,080
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on LinkedInFollow on LinkedIn

+ Translate

Treatment of acute bleeding with recombinant factor VIIa in a patient with IgA deficit receiving anticoagulant therapy



Treatment of acute bleeding with recombinant factor VIIa in a patient with IgA deficit receiving anticoagulant therapy



Acta Haematologica 110(1): 51-52




(PDF same-day service: $19.90)

Accession: 035980749

Download citation: RISBibTeXText

PMID: 12975561

DOI: 72418



Related references

Management of bleeding using recombinant factor VIIa in a patient suffering from bleeding tendency due to a lupus anticoagulant-hypoprothrombinemia syndrome. Thrombosis and Haemostasis 82(6): 1776-1778, 1999

Successful treatment with recombinant factor VIIa of therapy-resistant severe bleeding in a patient with acquired von Willebrand disease. American Journal of Hematology 66(4): 292-294, 2001

Treatment of bleeding with recombinant factor VIIa in a patient with extensive burns. Thrombosis and Haemostasis 91(1): 203-204, 2003

Recombinant factor VIIa treatment of bleeding associated with acute renal failure. Blood Coagulation & Fibrinolysis 11(6): 575-577, 2000

Pseudoprolongation of the prothrombin time during treatment with recombinant factor VIIa for bleeding in a patient with a spontaneous factor VIII inhibitor. International Journal of Hematology 77(3): 308-309, 2003

Successful use of recombinant factor VIIa in a bleeding patient with refractory thrombocytopenia undergoing chemotherapy for acute leukemia. Blood 94(10 SUPPL 1 PART 2): 239b, Nov 15, 1999

Treatment of Recurrent Gastrointestinal Bleeding with Recombinant Factor VIIa in a Patient with Bernard-Soulier Syndrome. Chirurgische Gastroenterologie 21(1): 78-79, 2005

Dose optimization of recombinant factor VIIa in the treatment of acute bleeding in haemophilia-associated inhibitors. Blood Coagulation & Fibrinolysis 14 Suppl 1: S29-S30, 2003

Use of Recombinant Factor VIIa in a Pediatric Patient With Initial Presentation of Refractory Acute Immune Thrombocytopenic Purpura and Severe Bleeding. Journal of Pediatric Pharmacology and Therapeutics 17(3): 274-280, 2012

Haematuria in a young patient with severe haemophilia and inhibitor presence receiving prophylactic treatment with recombinant factor VIIa. Blood Coagulation & Fibrinolysis 21(6): 611-613, 2011

Recombinant factor VIIa for intraoperative bleeding in a child with hepatoblastoma and review of recombinant activated factor VIIa use in children undergoing surgery. Journal of Pediatric Surgery 43(4): E15-E19, 2008

Effect of recombinant Factor VIIa on outcome of acute variceal bleeding: an individual patient based meta-analysis of two controlled trials. Journal of Hepatology 61(2): 252-259, 2015

Recombinant factor VIIa for the treatment of acute promyelocytic leukemia with severe bleeding: 8 cases report and literature review. Zhonghua Xue Ye Xue Za Zhi 36(2): 158-160, 2015

The use of recombinant factor VIIa (NovoSeven) in a patient with a factor XI deficiency and a circulating anticoagulant. Blood Coagulation & Fibrinolysis 12(7): 551-553, 2001

Sequential therapy with activated prothrombin complex concentrate (FEIBA) and recombinant factor VIIa in a patient with severe haemophilia A, inhibitor presence and refractory bleeding. Haemophilia 14(2): 390-391, 2008